The previous medwatch report was submitted by william cook europe under manufacturer report reference# 3002808486-2020-00133.Additional information provided determined that this device was manufactured by cook inc.With the submission of this initial medwatch report, cook inc.Informs that all future submissions regarding this complaint will be handled under the manufacturer report reference #.Initial reporter occupation: non-healthcare professional.(b)(4).Investigation: the following allegations have been investigated: venous/pulmonary embolism, vena cava perforation, embedment, clogged filter with clots, thrombosis of unspecified deep vessels of lower extremity, medical intervention to unclog device, unable to retrieve, tilt, swollen legs, pain, limited physical activity.Investigation is reopened due to additional information provided.The reported allegations have been further investigated based on the information provided to date.New pe as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: pulmonary embolism.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Ivc occlusion/ thrombosis, new dvt, ivc stenosis as a reported complication, is a known risk in relation to filter implant and is well documented in the clinical literature and in clinical practice guidelines.This is supported by the clinical evidence report established to assess available clinical data to identify and evaluate the clinical safety and performance of the cook vena cava filters.Potential adverse events that may occur include, but are not limited to, the following: vena cava occlusion or thrombosis, vena cava stenosis, deep vein thrombosis.Physician practice guidelines and published guidance from regulatory agencies recommend that patients with indwelling filters undergo routine follow-up.The risks/benefits of filter retrieval should be considered for each patient during follow-up.Once protection from pe is no longer necessary, filter retrieval should be considered.Filter retrieval should be attempted when feasible and clinically indicated.Filter retrieval is a patient-specific, clinically complex decision; the decision to remove a filter should be based on each patient¿s individual risk/benefit profile (e.G., a patient¿s continued need for protection from pe compared to their experience with and (or) ongoing risk of experiencing filter-related complications).For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.The filter is designed to be retrieved with the günther tulip vena cava filter retrieval set.It may also be retrieved with the cloversnare® vascular retriever.Cook has not performed testing to evaluate the safety or effectiveness of filter retrieval using other retrieval systems or techniques.The published clinical literature includes descriptions of alternative techniques for filter retrieval; use of these techniques varies according to physician experience, patient anatomy, and filter position.The safety or effectiveness of these alternative retrieval techniques has not been established.Specific for ¿embedded¿ a filter that is embedded in the wall of the ivc may be difficult to retrieve.For all retrievable ivc filters, retrieval becomes more challenging with time, and this is commonly due to encapsulation of the filter legs or hook (in a tilted filter) by tissue ingrowth.Filter tilt has been reported.Potential causes may include filter placement in ivcs with diameters larger than those specified in these instructions for use; improper deployment; manipulations near an implanted filter (e.G., a surgical or endovascular procedure in the vicinity of a filter); and (or) a failed retrieval attempt.Excessive filter tilt may contribute to difficult or failed retrieval; vena cava wall penetration/perforation; and (or) result in loss of filter efficiency.Potential adverse events that may occur include, but are not limited to, the following: unacceptable filter tilt.Unknown if the reported swollen legs, pain, limited physical activity are directly related to the filter and unable to identify a corresponding failure mode at this point in time.(b)(4) devices in lot.No relevant notes on work order.The product is manufactured and inspected according to specifications.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.
|
Patient allegedly received an implant on (b)(6) 2010 via left common femoral vein due to submassive pulmonary embolism and right ventricular (rv) dysfunction.Patient is alleging tilt, unable to retrieve, embedment.The patient further alleges swollen legs, pain, clogged filter with clots, medical intervention to unclog device, unable to do heavy lifting, limited physical activity, venous/pulmonary embolism, thrombosis of unspecified deep vessels of lower extremity, vena cava perforation.Attempted surgical removal on (b)(6) 2010 due to being in place 6 months and time for removal.On (b)(6) 2010, per a report from retrieval report (attempted); ¿diagnostic conclusions/overall summary: ivc and filter widely patent.Filter appeared to be well-endothelialized the hook into caval wall.Recommendations: sheath out.Elect to leave in indefinitely, given anatomy.Tolerating ac and no clinical problems w/filter, thus i feel safest course would be to leave in as permanent device.Diagnoses: chronic venous embolism and thrombosis of unspecified deep vessels of lower extremity.Pulmonary embolism.Peripheral findings: venous: inferior vena cavography: the ivc is widely patent.The filter is in original position, inferior to renal veins with slight tilt.There is no evidence of associated thrombus.¿ on (b)(6) 2019, per a report from computed tomography (ct); ¿findings: there is a gunther tulip type ivc filter in place in the inferior vena cava, the filter is tilted posteriorly towards the right at by approximately 11 [degrees] relative to the long axis of the ivc.The left posterior metallic strut is partially surrounded by phone/osteophyte at the anterior margin of the l3 - l4 disc.This extends outside of the ivc by up to 1 cm in length and 6 mm in the transverse plane.A left anterior strut extends close to and nearly contacts the outer wall of the abdominal aorta.No definite extension into the duodenum is seen.There is no broken fragment.The upper end of the filter is located just below the confluence of the right renal vein and ivc.Impression: gunther tulip type ivc filter in place as described which may be embedded in the spine at l3 - l4.No broken fragment is identified.¿.
|